A Phase I, Dose-Finding Study of Sorafenib in Combination with Gemcitabine and Radiation Therapy in Patients with Unresectable Pancreatic Adenocarcinoma: A Grupo Español Multidisciplinario en Cáncer Digestivo (GEMCAD) Study
Keyword(s):
Phase I
◽
2003 ◽
Vol 1
(5)
◽
pp. S174-S175
2019 ◽
Vol 55
(5)
◽
pp. 955-964
◽